The Worldwide Genomics Market report is an expert analysis report explore the market by Size, Share and Forecasts Till 2025. The Global Genomics Market size was estimated at USD 12.02 billion in 2016. It is anticipated to progress at a CAGR of 9.7% over the forecast period. Widening base of genomic data pool from genomic research activities is enabling physicians, biologists, and patients to further investigate genetic predisposition to certain diseases.


Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT uniquely focused on collaborative life science and technology campuses in AAA innovation cluster locations, today announced it has acquired 219 East 42nd Street for $203 million on a fee simple basis, through a membership interest in the purchasing entity 219/235 East LLC. As part of the transaction, 219/235 East LLC leased back 219 East 42nd Street on a triple net basis to Pfizer Inc., which announced earlier this year plans to relocate its global office headquarters to Manhattan’s Hudson Yards neighborhood in 2022. Ideally located in the heart of Manhattan’s East Side Medical Corridor with critical adjacency to New York City’s renowned academic and medical institutions, the acquisition of this approximately 350,000 RSF, 10-story office building represents significant and immediate net operating income growth with a strong yield from an investment-grade tenant.


Thursday, July 19, 20184:30 - 7:00 PM EST

Spend an inspiring 10 minute ‘ideastorming’ session with the Anchor Ventures PowerTen, the most influential innovation leaders in the greater Baltimore area – build on an idea for your company, bring your ideas for a program topic, a product, a system improvement or a better way to grow our ecosystem. Complete the RSVP link with your idea and we’ll match you to our PowerTen. Then mingle with more than 150 local entrepreneurs at our networking happy hour.


The Society of Physician Entrepreneurs and the MBA Collaborative Alumni Angel Group, in conjunction with NIH, cordially invite you to join us for our next meeting:

Summer Healthcare/Life Science Pitch Event

July 24th 2018 5 PM-8 PM

This program will be focused on start-up and emerging biotech, pharmaceutical, Health IT, and healthcare companies. Referrals are coming from NIH officials and consultants as well as SoPE/CAAG members and affiliates.

Call for Start-Ups; Please submit your Executive Summary and non-proprietary Slide deck to This email address is being protected from spambots. You need JavaScript enabled to view it. for consideration to pitch at this upcoming event.


Want to hear more about cybersecurity and technology in Montgomery County? Check out the personal stories from our most innovative business leaders and entrepreneurs in the fields of IT, BioHealth, life sciences, and more.


The Bill & Melinda Gates Foundation has held a coming-out party for its nonprofit biotech startup. Equipped with plans to build a 120-person team and spend $100 million a year, the Gates Medical Research Institute (MRI) will turn drug industry expertise and processes on intractable diseases that kill millions of people annually in low- and middle-income countries.


WellDoc®, a leading digital health company, today announces hypertension and weight management solutions integrated within its digital therapeutic app for type 2 diabetes, BlueStar®. Later this year, WellDoc will launch its stand-alone product for individuals living with hypertension (high blood pressure) and stand-alone products are also in development for multiple chronic diseases.

viela bio logo

When Viela Bio spun out of MedImmune in March, it started with six assets — three in clinical trials and three in preclinical development — putting it ahead of most startups and many spin-offs. “Other spin-offs often are developing assets that have been shelved for various reasons or that have been deprioritized,” Bing Yao, Ph.D., CEO, notes. “But for Viela Bio, this is a continuation of the programs, not a handoff.”


TEDCO, Maryland’s economic engine for technology companies, announced its recent investments through the Maryland Innovation Initiative (MII). With the latest round of funding, MII’s funding count for FY18 includes 38 technology assessment grants and seven start-up investments for a total of $5.56 million. True to its technology agnostic funding history, this year the startups ranged from medical devices to aeronautics and the sports industry.


The quest for innovation is a major driving force in pharma. From the discovery of therapeutic biologicals in the 1920s, such as Salvarsan and insulin, to the blockbuster drugs birthed in the 1990s, such as Lipitor and Humira, pharma has always been on a quest for novel, groundbreaking drug development.


WellDoc®, a leading digital health company revolutionizing chronic disease management to help transform lives through the use of its digital therapeutics, today announced results from an innovative economic analysis that demonstrated the potential for significant healthcare cost savings with the use of BlueStar®. BlueStar is powered by WellDoc and is a 510K-cleared digital therapeutic designed to coach adults with type 2 diabetes.


CosmosID a bioinformatics provider and NGS service laboratory announced that the company’s cloud-based bioinformatics platform for microbiome analysis has received the highest score in the strain-level microbial profiling category of the Mosaic Community Challenge and for strain-level microbial identification in the precisionFDA Pathogen Detection Challenge.